author-photo

Cynthia C McCoig

Research Triangle Park

4

Papers

4

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

LB-8. Summary of COVID-Related Impact on Cabotegravir and Rilpivirine Long-Acting (CAB+RPV LA) Dosing Across the Six Ongoing Global Phase IIb and IIIb Clinical Trials

2020 Open Forum Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (1)
1029. Long-Term Patient Adherence and Management of Treatment Interruptions With Long-Acting Injectable Cabotegravir + Rilpivirine for Maintenance Therapy in Phase IIb/III Studies

2020 Open Forum Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (1)
116. Antiviral Activity and Safety of Long-acting Cabotegravir (CAB LA) Plus Long-acting Rilpivirine (RPV LA), Administered Every 2 Months (Q2M), in Hiv-positive Subjects: Results from the POLAR Study

2020 Open Forum Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (1)